Literature DB >> 17114453

A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.

Jan-Luuk Hillebrands1, Barbara Whalen, Jeroen T J Visser, Jasper Koning, Kenneth D Bishop, Jean Leif, Jan Rozing, John P Mordes, Dale L Greiner, Aldo A Rossini.   

Abstract

Biobreeding (BB) rats model type 1 autoimmune diabetes (T1D). BB diabetes-prone (BBDP) rats develop T1D spontaneously. BB diabetes-resistant (BBDR) rats develop T1D after immunological perturbations that include regulatory T cell (Treg) depletion plus administration of low doses of a TLR ligand, polyinosinic-polycytidylic acid. Using both models, we analyzed CD4+CD25+ and CD4+CD45RC- candidate rat Treg populations. In BBDR and control Wistar Furth rats, CD25+ T cells comprised 5-8% of CD4+ T cells. In vitro, rat CD4+CD25+ T cells were hyporesponsive and suppressed T cell proliferation in the absence of TGF-beta and IL-10, suggesting that they are natural Tregs. In contrast, CD4+CD45RC(-) T cells proliferated in vitro in response to mitogen and were not suppressive. Adoptive transfer of purified CD4+CD25+ BBDR T cells to prediabetic BBDP rats prevented diabetes in 80% of recipients. Surprisingly, CD4+CD45RC-CD25- T cells were equally protective. Quantitative studies in an adoptive cotransfer model confirmed the protective capability of both cell populations, but the latter was less potent on a per cell basis. The disease-suppressing CD4+CD45RC-CD25- population expressed PD-1 but not Foxp3, which was confined to CD4+CD25+ cells. We conclude that CD4+CD25+ cells in the BBDR rat act in vitro and in vivo as natural Tregs. In addition, another population that is CD4+CD45RC-CD25- also participates in the regulation of autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114453     DOI: 10.4049/jimmunol.177.11.7820

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.

Authors:  Daniela Farkas; Aysar A Alhussaini; Donatas Kraskauskas; Vita Kraskauskiene; Carlyne D Cool; Mark R Nicolls; Ramesh Natarajan; Laszlo Farkas
Journal:  Am J Respir Cell Mol Biol       Date:  2014-09       Impact factor: 6.914

2.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 3.  Regulatory T cells and pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Mark R Nicolls
Journal:  Trends Cardiovasc Med       Date:  2011-08       Impact factor: 6.677

4.  Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

Authors:  Rasa Tamosiuniene; Wen Tian; Gundeep Dhillon; Lijuan Wang; Yon K Sung; Lajos Gera; Andrew J Patterson; Rani Agrawal; Marlene Rabinovitch; Kelly Ambler; Carlin S Long; Norbert F Voelkel; Mark R Nicolls
Journal:  Circ Res       Date:  2011-08-25       Impact factor: 17.367

Review 5.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

6.  GIMAP GTPase family genes: potential modifiers in autoimmune diabetes, asthma, and allergy.

Authors:  Mirkka T Heinonen; Antti-Pekka Laine; Cilla Söderhäll; Olena Gruzieva; Sini Rautio; Erik Melén; Göran Pershagen; Harri J Lähdesmäki; Mikael Knip; Jorma Ilonen; Tiina A Henttinen; Juha Kere; Riitta Lahesmaa
Journal:  J Immunol       Date:  2015-05-11       Impact factor: 5.422

Review 7.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 8.  Closing the circle between the bedside and the bench: Toll-like receptors in models of virally induced diabetes.

Authors:  Rita Bortell; Steven C Pino; Dale L Greiner; Danny Zipris; Aldo A Rossini
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.

Authors:  Christian W Grant; Shane K Duclos; Catherine M Moran-Paul; Barak Yahalom; Rebecca S Tirabassi; Guillermo Arreaza-Rubin; Lisa M Spain; Dennis L Guberski
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

10.  Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function.

Authors:  J Visser; J L Hillebrands; M Walther Boer; N A Bos; J Rozing
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.